HUCS 001
Alternative Names: HUCS-001Latest Information Update: 31 Mar 2025
At a glance
- Originator RAINBOW
- Class
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Research Spinal cord injuries
Most Recent Events
- 18 Mar 2025 Early research in Spinal cord injuries in Japan (unspecified route) prior to March 2025 (RAINBOW Pipeline, March 2025)